Trial Profile
A Randomised study to evaluate the efficacy and safety of 12-monthly versus 4-monthly injections of botulinum toxin A (BoNT-A) in ambulant children with spastic equinus, secondary to cerebral palsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Equinus foot deformity; Muscle spasticity
- Focus Therapeutic Use
- 17 May 2017 New trial record